24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Advent
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
12:50
“Younger people are getting cancer more and more…we have to make kinder medicines.”
11:42
Armis sale to ServiceNow could yield $4 billion windfall for Insight Partners
10:40
Once valued at $600 million, what went wrong at collapsing Believer Meats
09:39
Shipping giant MSC submits bid for ZIM, challenging Hapag-Lloyd in takeover race
More stories
Buzz
Most popular
Daily
Weekly
1
Oracle’s stock has fallen 40% since Safra Catz announced her exit. Its latest earnings didn’t calm investors.
2
Freed Nvidia engineer Avinatan Or meets Jensen Huang at U.S. headquarters
3
After over $390 million in funding, Believer Meats abruptly shuts down
4
Jensen Huang’s quiet role emerges as Argamani describes Nvidia’s two-year vigil for Avinatan Or
5
ServiceNow in advanced talks to acquire Armis at around $7 billion valuation
More news
Advent
5 stories about Advent
Advent bets on cloud transition with $2.5 billion Sapiens acquisition
14.08.25
|
Almog Azar
Insurtech’s U.S. market ambitions hinge on private equity’s deep network.
Advent to acquire Sapiens for $2.5 billion, ending its public market run
13.08.25
|
Almog Azar, CTech
Insurance software maker to go private at 64% premium as private equity bets on SaaS and AI transformation.
BigPanda enters unicorn club with $190 million funding at $1.2 billion valuation
12.01.22
|
Meir Orbach
The IT management company raised the sum in two rounds over a month-and-a-half in late 2021
Advent Delays $1.9 Billion ForeScout Acquisition
19.05.20
|
Hagar Ravet
The companies are in ongoing discussions concerning the timing and terms of completion, but, according to ForeScout, there can be no assurance that they could reach an agreement
Cerberus, Advent Eye Teva's European Assets, Report Says
15.08.17
|
Calcalist
The private equity firms are taking an interest in Teva's European oncology and pain treatment assets, estimated at $700 million to 1$ billion, according to a Bloomberg report